Immunic, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Immunic, Inc. (IMUX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -0.20% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-04.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2019-03-04
- Immunic, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2018 was -0.20%.
- Immunic, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2017 was -46.80%.
- Immunic, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2016 was -2.90%.
- Immunic, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2015 was -3.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2018-12-31 | -0.20% 10-K · filed 2019-03-04 |
| 2017-12-31 | -46.80% 10-K · filed 2019-03-04 |
| 2016-12-31 | -2.90% 10-K · filed 2019-03-04 |
| 2015-12-31 | -3.00% 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |